Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ.

N Engl J Med. 2012 May 24;366(21):1968-77. doi: 10.1056/NEJMoa1113354. Epub 2012 May 20.

2.

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G.

N Engl J Med. 2014 May 29;370(22):2093-101. doi: 10.1056/NEJMoa1401739. Epub 2014 May 18.

3.

High-dose acetylcysteine in idiopathic pulmonary fibrosis.

Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M; IFIGENIA Study Group.

N Engl J Med. 2005 Nov 24;353(21):2229-42.

4.

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial.

Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Lankhorst I, Sardina M, Boissard G; IFIGENIA study group.

Respir Res. 2009 Oct 27;10:101. doi: 10.1186/1465-9921-10-101.

5.

Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.

Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, Hutchinson J, Pardee NE, Winterbauer RH.

Am Rev Respir Dis. 1991 Aug;144(2):291-6.

PMID:
1859050
6.
7.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.

Arthritis Rheum. 2006 Dec;54(12):3962-70.

8.

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Izumi S, Iikura M, Hirano S.

N Engl J Med. 2012 Aug 30;367(9):870; author reply 870-1. doi: 10.1056/NEJMc1207471#SA3. No abstract available.

PMID:
22931326
9.

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Uruga H, Hanada S, Kishi K.

N Engl J Med. 2012 Aug 30;367(9):870; author reply 870-1. doi: 10.1056/NEJMc1207471#SA2. No abstract available.

PMID:
22931325
10.

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Behr J.

N Engl J Med. 2012 Aug 30;367(9):869; author reply 870-1. doi: 10.1056/NEJMc1207471#SA1. No abstract available.

PMID:
22931324
11.

Treatment switching in idiopathic pulmonary fibrosis: from triple therapy to enrollment into a clinical investigational drug trial.

Valenzuela C, Ancochea J.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Sep 1;30 Suppl 1:44-7.

PMID:
24081245
12.

Antioxidant therapy for idiopathic pulmonary fibrosis.

Hunninghake GW.

N Engl J Med. 2005 Nov 24;353(21):2285-7. No abstract available.

PMID:
16306527
13.

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.

King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM; INSPIRE Study Group.

Lancet. 2009 Jul 18;374(9685):222-8. doi: 10.1016/S0140-6736(09)60551-1. Epub 2009 Jun 29.

PMID:
19570573
14.

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Behr J, Bendstrup E, Crestani B, Günther A, Olschewski H, Sköld CM, Wells A, Wuyts W, Koschel D, Kreuter M, Wallaert B, Lin CY, Beck J, Albera C.

Lancet Respir Med. 2016 Jun;4(6):445-53. doi: 10.1016/S2213-2600(16)30044-3. Epub 2016 May 5.

PMID:
27161257
15.

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients.

Huang H, Dai HP, Kang J, Chen BY, Sun TY, Xu ZJ.

Medicine (Baltimore). 2015 Oct;94(42):e1600. doi: 10.1097/MD.0000000000001600.

16.

Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.

Nathan SD.

Clin Chest Med. 2006 Mar;27(1 Suppl 1):S27-35, vi. Review.

PMID:
16545630
17.
18.

Current perspectives on the treatment of idiopathic pulmonary fibrosis.

Walter N, Collard HR, King TE Jr.

Proc Am Thorac Soc. 2006 Jun;3(4):330-8. Review.

PMID:
16738197
19.

Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.

Sakamoto S, Muramatsu Y, Satoh K, Ishida F, Kikuchi N, Sano G, Sugino K, Isobe K, Takai Y, Homma S.

Respirology. 2015 Apr;20(3):445-52. doi: 10.1111/resp.12477. Epub 2015 Feb 2.

20.

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.

Suter PM, Domenighetti G, Schaller MD, Laverrière MC, Ritz R, Perret C.

Chest. 1994 Jan;105(1):190-4.

PMID:
8275731

Supplemental Content

Support Center